Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023


Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2023 financial results will be released on Tuesday, May 9, 2023 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company's website.

To access the conference call, please register using this link. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. A webcast replay of the conference call will also be archived on www.exelixis.com for one year.

About Exelixis

Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by bi-coastal centers of discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on Twitter, like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.

Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks.


These press releases may also interest you

at 12:05
Transaction in Own Shares
Transaction in Own Shares 4 July, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 4 July, 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to...

at 12:04
Canadian Investment Regulatory Organization Trade Resumption - VGCX
Trading resumes in: Company: Victoria Gold Corp. TSX Symbol: VGCX All Issues: Yes Resumption (ET): 12:15 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...

at 12:00
USO and John Deere Join Forces To Support Those Who Serve
John Deere has made a two-year, $100,000 commitment to USO, the leading nonprofit dedicated to strengthening the wellbeing of America's military members and their families. This donation will enable John Deere employees and customers to show their...

at 11:46
MAGNETIC NORTH ACQUISITION CORP. PROVIDES BI-WEEKLY UPDATE ?ON STATUS OF MANAGEMENT CEASE TRADE ORDER ?
Magnetic North Acquisition Corp.  ("Magnetic North" or the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on May 7, 2024 (the "MCTO") by its principal regulator, the Alberta Securities...

at 11:25
CSL Highlights Major ESG Achievements in 2023 Sustainability Report
The CSL Group ("CSL"), a global leader in sustainable marine transportation solutions, today unveiled its 2023 Corporate Sustainability Report, reflecting its commitment to transparency and accountability in environmental, social, and governance...

at 11:24
Canadian Investment Regulatory Organization Trade Resumption - GXU
Trading resumes in: Company: GoviEx Uranium Inc. TSX-Venture Symbol: GXU All Issues: Yes Resumption (ET): 11:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts...

More news about Business...


News published on and distributed by: